Walleye Capital LLC Novo Cure LTD Put Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $82,810 - $168,350	7,000 Added 7000.0%	7,100 $121,000
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $18,630 - $25,935	-1,500 Reduced 93.75%	100 $1,000
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $50,085 - $71,010	-4,500 Reduced 73.77%	1,600 $23,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $30,684 - $80,465	1,900 Added 45.24%	6,100 $98,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $342,465 - $701,335	-8,500 Reduced 66.93%	4,200 $174,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $694,212 - $1.46 Million	12,300 Added 3075.0%	12,700 $763,000
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $479,850 - $640,275	-7,500 Reduced 94.94%	400 $29,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $537,121 - $707,603	7,900 New	7,900 $600,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $484,930 - $665,980	-7,100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $37,116 - $58,680	600 Added 9.23%	7,100 $531,000
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $215,322 - $322,473	5,100 Added 364.29%	6,500 $411,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $44,744 - $78,568	1,400 New	1,400 $67,000

272

77.2M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.